Talk:Papillary thyroid carcinoma: Difference between revisions
Jump to navigation
Jump to search
→IHC: new section |
No edit summary |
||
| Line 8: | Line 8: | ||
CD56+, CK19 -ve, p63 -ve goes against PTC https://www.ncbi.nlm.nih.gov/pubmed/18254952 | CD56+, CK19 -ve, p63 -ve goes against PTC https://www.ncbi.nlm.nih.gov/pubmed/18254952 | ||
==Variation of thyroid cancer in Canada== | |||
Variation by City: https://journalotohns.biomedcentral.com/articles/10.1186/s40463-015-0088-0/tables/1 | |||
Variation by Province: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621959/ | |||